Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Research analysts at Roth Capital issued their Q4 2024 earnings per share (EPS) estimates for shares of Cresco Labs in a note issued to investors on Sunday, November 10th. Roth Capital analyst W. Kirk anticipates that the company will post earnings of ($0.01) per share for the quarter. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share. Roth Capital also issued estimates for Cresco Labs’ Q1 2025 earnings at ($0.01) EPS, Q2 2025 earnings at $0.00 EPS, Q3 2025 earnings at $0.00 EPS, Q4 2025 earnings at $0.00 EPS and FY2025 earnings at ($0.01) EPS.
Several other analysts also recently commented on the stock. Needham & Company LLC restated a “hold” rating on shares of Cresco Labs in a research report on Monday, August 12th. Ventum Cap Mkts raised shares of Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $2.50.
Cresco Labs Stock Performance
OTCMKTS:CRLBF opened at $1.44 on Wednesday. The stock has a 50-day simple moving average of $1.58 and a two-hundred day simple moving average of $1.71. Cresco Labs has a 52-week low of $1.02 and a 52-week high of $2.65. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.30 and a current ratio of 2.00. The firm has a market capitalization of $702.92 million, a PE ratio of -7.10 and a beta of 1.88.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Featured Articles
- Five stocks we like better than Cresco Labs
- Industrial Products Stocks Investing
- Rocket Lab is the Right Stock for the Right Time
- Canada Bond Market Holiday: How to Invest and Trade
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Investing in Commodities: What Are They? How to Invest in Them
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.